Zeit | Aktuelle Nachrichten | ||
---|---|---|---|
Mi | Hardide Signs 10-year Supply Deal With Aerospace Customer; Stock Climbs | ||
Mi | Character Group FY24 Profit Rises, Maintains Dividend, Plans Addl Buyback; Sees Flat Results In FY25 | ||
Mi | Faraday Future Unveils In-car Software Updates For FF 91 2.0 Futurist Alliance EV | ||
Mi | Norwood Financial Prices Public Offering Of 1 Mln Shares At $26.00/shr | ||
Mi | Dye & Durham Appoints Hans Gieskes As Chair Of Board And Interim CEO | ||
Di | Worthington Industries Inc. Q2 Profit Advances | ||
Di | Sirius Real Estate Acquires Munich Business Park For 13.3 Mln Euros | ||
Di | Northwest Bancshares To Acquire Penns Woods In All-stock Deal | ||
Di | Tenaya Reports Early Data From First Cohort Of Patients In MyPEAK-1 Trial Of TN-201 | ||
Di | EVgo Announces Pricing Of Secondary Offering Of Class A Stock | ||
Di | REE Automotive Posts Wider Loss In Q3 | ||
Di | Marker Therapeutics Awarded $9.5 Mln Grant From CPRIT For MT-601 In Metastatic Pancreatic Cancer | ||
Di | Viad Names Michael Heitz CFO, Succeeding Ellen Ingersoll, Effective March 2025 | ||
Di | CGI Group Inks 25-year Agreement With SkyAlyne For Future Aircrew Training Program In Canada | ||
Di | Skanska Invests EUR 76 Mln In Second Phase Of H2Offices Project In Hungary | ||
Di | Hollywood Bowl Group FY Pre-tax Profit Down | ||
Di | Thyssenkrupp Nucera AG & Co. KGaA Q4 Profit Surges - Update | ||
Di | Goodwin H1 Profit Climbs On Revenue Growth; Sees Similar Results In H2 | ||
Di | Thyssenkrupp Nucera AG & Co. KGaA Q4 Profit Drops - Update | ||
Di | Sandoz To Pay $275 Mln To Resolve US Generic Drug Litigation, Plans $265 Mln Provision; Backs View | ||
Di | Davis Commodities Signs $15 Mln MoU With Dadvance Agarwood To Boost Luxury Wellness Business | ||
Di | La-Z-Boy Elects President And CEO Melinda Whittington As Chair | ||
Di | EBay Authorizes $3 Bln Increase For Stock Repurchase Program | ||
Di | Altisource Portfolio Solutions Enters Agreement With Lenders For Term Loans Exchange And Extension | ||
Di | Jazz Pharma CEO Bruce Cozadd To Retire |